📈 Jumpstart Signal Watchlist — August 11, 2026

🏢 What they do: BioCryst Pharmaceuticals is a biotechnology company that develops and commercializes medicines for hereditary angioedema (HAE) and other rare diseases. Its key products include ORLADEYO for preventing HAE attacks and RAPIVAB for treating influenza, and it is also advancing additional rare-disease drug candidates.
- 🎯 Current $10.34 is 8% below 3yr high $11.19 · ⏳ SMA200 $8.30 (current price $10.34 is above) · 💰 Market Cap $2.6B
- BCRX shows decent technicals supported by positive sentiment.

💎 Quality (Q): 28/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1400% (>20%); Revenue growth 34% (>15%).
⏰ Entry (E): 7/20
- 🔔 Strong above EMA21 (9.0%)
- 🔔 Strong above EMA50 (10.1%)
- 📈 RSI at 63 showing strength
- ⚠️ SMA20/SMA50 bearish crossover
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive.
✅ BioCryst Pharmaceuticals Q2 Earnings Call Highlights — finance.yahoo.com.
🤖 BioCryst reported stronger second-quarter operating results, including ORLADEYO revenue growth, pediatric oral-pellet shipments, and completion of enrollment in the pivotal navenibart trial. The company also reaffirmed its outlook, which is constructive for the stock.
✅ BioCryst Pharmaceuticals (NASDAQ:BCRX) Issues Earnings Results — MarketBeat.
🤖 The company beat consensus EPS and revenue estimates for Q2 2026 and raised full-year revenue guidance to $690 million-$715 million. Investors also reacted positively to the combination of strong sales, improved guidance, and continued pipeline progress.
⚪️ RBC Adjusts Price Target on BioCryst Pharmaceuticals to $13 From $14, Maintains Outperform Rating — Yahoo Finance.
🤖 RBC trimmed its price target but kept an Outperform rating, which is mixed rather than clearly bullish or bearish. The lower target may pressure sentiment somewhat, but the maintained positive rating offsets part of that impact.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States, focused on helping employers manage workplace injuries and employee health. Its services include occupational health centers, onsite employer clinics, telemedicine, workers’ compensation care, and other direct-to-employer health services.
- 🎯 Current $33.03 is 3% below 3yr high $34.10 · ⏳ SMA200 $23.79 (current price $33.03 is above) · 💰 Market Cap $4.2B
- CON shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (13.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 46% (>20%); ROE 42% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 4/20
- 🔔 Strong above EMA50 (10.0%)
- 📈 RSI at 61 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Concentra Q2 2026 slides: margin surge drives guidance raise — Investing.com.
🤖 Concentra reported strong second-quarter 2026 results with 10% revenue growth and expanded adjusted EBITDA margins, and it raised full-year 2026 guidance. Higher outlook and improving profitability are generally supportive for the stock price.
✅ Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2026 and Raises FY 2026 Guidance — Business Wire.
🤖 The company posted solid Q2 results, including 10.0% revenue growth, 22.5% adjusted EBITDA growth, and a 46.5% increase in net income attributable to the company, then raised full-year guidance. It also declared a cash dividend, which adds another supportive signal for investors.
✅ Concentra Group Holdings Parent, Inc. 2026 Q2 - Results - Earnings Call Presentation — Seeking Alpha.
🤖 The presentation highlights that Concentra beat on both EPS and revenue and raised 2026 revenue and adjusted EBITDA targets. It also notes a planned CEO transition, but the dominant takeaway for the stock is stronger operating performance and higher guidance.
🍭 Bonus (B): 0/10 — Specialty Outpatient Facilities

🏢 What they do: Park Aerospace Corp develops and manufactures advanced composite materials, primary and secondary structures, and assemblies for the aerospace and defense industries. The company produces high-technology materials including epoxy prepregs, composite materials, and printed circuit board materials used in aircraft structures, interiors, and electronic interconnection systems.
- 🎯 Current $37.47 is 2% below 3yr high $38.23 · ⏳ SMA200 $27.78 (current price $37.47 is above) · 💰 Market Cap $782M
- PKE shows decent technicals supported by positive sentiment.

💎 Quality (Q): 48/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 70% (>20%); Revenue growth 19% (>15%); Low LT D/E 0.55 (<1.0); PEG ratio 0.85 (<1.5).
⏰ Entry (E): 6/20
- 🔔 Strong above EMA21 (5.2%)
- 🔔 SMA20/SMA50 bullish crossover
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Citizens reiterates Park Electrochemical stock rating on strong results — Investing.com.
🤖 Citizens maintained a Market Outperform rating and $42 price target after Park reported Q1 fiscal 2027 revenue and EPS above expectations. The note points to stronger margins and demand in aerospace and defense as supportive for the stock.
✅ Earnings call transcript: Park Aerospace tops Q1 2026 estimates shares jump 7.2% — Investing.com.
🤖 Park reported EPS and revenue above estimates and guided second-quarter sales and adjusted EBITDA above the prior quarter, which investors read as a constructive outlook. Shares rose sharply in after-hours trading after the release.
✅ Park Aerospace Corp. Reports First Quarter Results — Yahoo Finance / GlobeNewswire.
🤖 The company reported Q1 fiscal 2027 results for the period ended May 31, 2026, including net sales of $18.312 million and net earnings of $3.533 million. The release provides the financial basis for the earnings beat that drove a favorable market reaction.
🍭 Bonus (B): 0/10 — Aircraft Parts

🏢 What they do: HF Sinclair Corporation (DINO) is an independent energy company that operates refineries across the mid-continent, Southwest, Rocky Mountain regions, and Pacific Northwest in the United States, producing and marketing gasoline, diesel fuel, jet fuel, renewable diesel, specialty lubricants, chemicals, and asphalt.
- 🎯 Current $85.55 is 8% below 3yr high $92.44 · ⏳ SMA200 $61.38 (current price $85.55 is above) · 💰 Market Cap $19.1B
- DINO shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 348% (>20%); Revenue growth 53% (>15%); ROE 19% (>15%); Low LT D/E 0.27 (<1.0).
⏰ Entry (E): 0/20
- 📈 RSI at 53 in healthy mid-range
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (mixed coverage).
✅ HF Sinclair (DINO) After Earnings Jump And Spinoff Plan Looks ... — Yahoo Finance.
🤖 This article highlights HF Sinclair’s sharp second-quarter earnings increase, a 5% dividend boost, and a plan to spin off its Lubricants and Specialties segment. Those actions are generally supportive for the stock because they point to stronger profitability and potential value creation.
✅ How Investors Are Reacting To HF Sinclair (DINO) Earnings Beat ... — Yahoo Finance.
🤖 The piece focuses on HF Sinclair’s strong quarterly results, higher dividend, and operational updates. Positive earnings momentum and shareholder returns are favorable for $DINO.
❌ HF Sinclair stock downgraded to Sell by Freedom Broker on valuation — Investing.com.
🤖 Freedom Broker cut HF Sinclair to Sell from Hold and set a $73 target, citing valuation after the stock’s strong rally. The downgrade is a negative signal for $DINO despite the company’s strong Q2 results.
🍭 Bonus (B): 0/10 — Pipelines (Except Natural Gas)

🏢 What they do: CBL & Associates Properties, Inc. (CBL) is a real estate investment trust (REIT) that owns and manages a national portfolio of retail properties, including enclosed malls, outlet centers, lifestyle centers, and open-air centers across 20 states. The company focuses on active management, leasing, redevelopment, and creating integrated shopping experiences with retail, dining, and entertainment.
- 🎯 Current $56.91 is 5% below 3yr high $60.05 · ⏳ SMA200 $41.62 (current price $56.91 is above) · 💰 Market Cap $1.8B
- CBL shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 Low drawdown (9.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1738% (>20%); ROE 51% (>15%); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ CBL Properties Announces Q2 2026 Earnings Results — MarketBeat.
🤖 CBL reported Q2 2026 EPS of $1.47 and revenue of $146.48 million, which was a confirmed results release rather than a future announcement. The latest earnings data is constructive for sentiment because it provides concrete operating results for the quarter.
🍭 Bonus (B): 0/10 — REITs

🏢 What they do: Innovex International, Inc. is an oilfield equipment and services company that designs, manufactures, sells, and rents engineered products for the global oil and natural gas industry. Its offerings support the well lifecycle—from well construction and completion to production and intervention—including subsea and surface wellhead systems, completion tools, and related field services.
- 🎯 Current $30.14 is 5% below 3yr high $31.63 · ⏳ SMA200 $24.67 (current price $30.14 is above) · 💰 Market Cap $2.1B
- INVX shows favorable technicals but negative sentiment warrants caution.

💎 Quality (Q): 46/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 64% (>20%); Low LT D/E 0.02 (<1.0); PEG ratio 0.53 (<1.5).
⏰ Entry (E): 9/20
- 🔔 Strong above EMA21 (7.8%)
- 🔔 Strong above EMA50 (11.1%)
- 🔔 SMA20/SMA50 bullish crossover
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 61 showing strength
📢 Sentiment (S): 4/10
- 🗞️ News sentiment is negative (mixed coverage).
✅ Innovex International, Inc. 2026 Q2 - Results - Earnings Call Presentation — Seeking Alpha.
🤖 The Q2 results show a revenue beat and guidance for Q3 revenue of $260 million to $270 million, supported by the recent TCO acquisition. Strong reported growth and upward-looking guidance are constructive for the stock, despite the secondary offering news.
✅ Innovex Announces Second Quarter 2026 Results — Business Wire.
🤖 Innovex reported revenue of $245 million, adjusted EBITDA of $48 million, and free cash flow of $30 million, all signaling solid execution and profitability. The company also ended the quarter with $222 million of cash and no bank debt and raised Q3 guidance, which is generally favorable for valuation.
❌ Innovex co-invest fund, director, sells $143.5 m in INVX stock — Investing.com.
🤖 A large insider/affiliate stock sale tied to the secondary offering can create near-term overhang and may pressure the share price, even though it is not a direct sale by the operating company. The article also notes the company’s completed TCO acquisition and a Jefferies buy rating, but the dominant market signal is the sizeable sale.
❌ Innovex International announces 5M-share secondary offering — Seeking Alpha.
🤖 The announcement of a 5 million-share secondary offering by affiliates of Amberjack Capital Partners is typically negative for the stock because it increases potential supply and can signal selling pressure. The company does not receive proceeds, so the transaction is mainly a dilution/overhang issue for shareholders rather than a growth catalyst.
🍭 Bonus (B): 0/10 — Oil & Gas Field Machinery